"In-play/dynamic” patients are the target group for commercial teams to grow their market shares and for brand teams to influence the decisions of their target physicians.
To maximize these critical opportunities, commercial teams need quantifiable data that provides the "real" reasons behind "why" brands are chosen by treating physicians.
RxY specializes in understanding these decisions and provides detailed reports and dashboards that empower brand teams to meet this goal.
AI chatbot technology probes and elicits physician responses after prescribing a therapy.
Voice capture is deployed for physicians to communicate the reasons behind their decisions.
Our data is captured within 24-48hrs of the prescribing decision.
Our reports and dashboards are custom built for each client.
Dermatology
Atopic Dermatitis, Psoriasis, Hidradenitis Suppurativa, Alopecia Areata
Neuroscience
Multiple Sclerosis, Alzheimer's Disease, Myasthenia Gravis, Epilepsy
Rheumatology
Psoriatic Arthritis, Rheumatoid Arthritis, Axial Spondyloarthritis
Gastroenterology
Ulcerative Colitis, Crohn’s Disease
Hematology
Chronic Lymphocytic Leukemia, Multiple Myeloma
Oncology
mNSCLC, Metastatic Breast Cancer, Prostate Cancer
Endocrinology
Type 2 Diabetes
Respiratory
Asthma, COPD
Cardiometabolic
Type 2 Diabetes, Obesity, Heart Failure, Chronic Kidney Disorder
Respiratory
Asthma, COPD
- June 2022: Efficacy as a Driver of Psoriasis Treatment Decisions in the U.S.: Dermatologists vs Nurse Practitioners/Physician Assistants Download Article Here
- September 2023: Global comparison of Oral JAK Inhibitors for Atopic Dermatitis Download Article Here
- March 2024: Exciting Developments in Atopic Dermatitis Treatment in China Download Article Here
- May 2024: Identifying Disparities in Atopic Dermatitis Treatment Download Article Here
- August 2024: Underutilization of biomarker testing and DMT treatment among patients with MCI due to suspected Alzheimer's disease Download Article Here
- More to come soon!
"RxY allows me to understand how physicians make prescribing decisions for their patients and what the drivers and barriers are for my brand."
US Business Intelligence Lead
"When we could not understand why our brand was not meeting growth expectations, we turned to RxY. Within 6 weeks, we had answers."
Global Insights Lead
“RxY provides the information my team needs to complete our overall understanding of physician decision-making.”
Director Marketing Insights
"When I saw the RxY insights, I knew we needed to develop a switch campaign for our portfolio."
Global Commercial Lead
“When I saw this product’s consideration rate 6 months after launch, I knew this could be bigger than the current market leader."
European Commercial Lead
By submitting the contact form you consent to RxY using this information to respond to your inquiry. If you want to know more about our privacy policy please click here.
1140 Avenue of the Americas 14th Floor
New York, NY
10036
1801 McGill College
Suite 1000
Montreal, Canada
H3A 2N4
Fourth Floor
16 Dufour's Place
London
W1F 7SP
1, Rue Hildegard Von Bingen
L-1282
Luxembourg
18 Rue des Remparts d'Ainay 69002
Lyon
France
11 Imam Haron Road
Claremont
Cape Town, 7708
South Africa
Prolongación Bernardo Quintana No. 300, 1202 Col. Centro Sur Querétaro, 76090
Mexico
Unit 1, Level 10, Block B, East Wing
PJ8, No. 23, Jalan Barat, Seksyen 8 46050 Petaling Jaya Selangor Darul Ehsan, Malaysia
